Pteridines Useful As HCV Inhibitors And Methods For The Preparation Thereof
The present invention relates to the use of pteridines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to compounds per se and their use as medicines. The present invention also c...
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
09.06.2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to the use of pteridines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to compounds per se and their use as medicines. The present invention also concerns processes for the preparation of such compounds, pharmaceutical compositions comprising them, and combinations of said compounds with other anti-HCV agents. |
|---|---|
| AbstractList | The present invention relates to the use of pteridines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to compounds per se and their use as medicines. The present invention also concerns processes for the preparation of such compounds, pharmaceutical compositions comprising them, and combinations of said compounds with other anti-HCV agents. |
| Author | SIMMEN KENNETH ALAN RABOISSON PIERRE JEAN-MARIE BERNARD SURLERAUX DOMINQUE LOUIS NESTOR GHISLAIN LENZ OLIVER LIN TSE-I |
| Author_xml | – fullname: SIMMEN KENNETH ALAN – fullname: RABOISSON PIERRE JEAN-MARIE BERNARD – fullname: LENZ OLIVER – fullname: LIN TSE-I – fullname: SURLERAUX DOMINQUE LOUIS NESTOR GHISLAIN |
| BookMark | eNqNys0KgkAUhuFZ1KK_ezjQOkjFcCuSGBEIaVuZ8hMH5ByZM91_BF1Aq5cH3rVZsDBW5loHeNc7hlKrGN4T5UpV8aALj-7pgnilnHu6IYzSK5XiqRlBtcdsvQ1O-GsPGbZmOdhJsft1Y_bluSmqA2bpoLN9gRG69h4fo1OUZnGS5VHy3_UBumQ26A |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US2016158238A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US2016158238A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:57:51 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US2016158238A13 |
| Notes | Application Number: US201615042299 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160609&DB=EPODOC&CC=US&NR=2016158238A1 |
| ParticipantIDs | epo_espacenet_US2016158238A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20160609 |
| PublicationDateYYYYMMDD | 2016-06-09 |
| PublicationDate_xml | – month: 06 year: 2016 text: 20160609 day: 09 |
| PublicationDecade | 2010 |
| PublicationYear | 2016 |
| RelatedCompanies | JANSSEN SCIENCIES IRELAND UC |
| RelatedCompanies_xml | – name: JANSSEN SCIENCIES IRELAND UC |
| Score | 3.0285616 |
| Snippet | The present invention relates to the use of pteridines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Pteridines Useful As HCV Inhibitors And Methods For The Preparation Thereof |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160609&DB=EPODOC&locale=&CC=US&NR=2016158238A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt2FH27V5GNK1K1XZVtw69jb6kWJhpKPt8N_3Ejfd095yCVw-yOVyyd3vAJ7VNDWjKNU6CcMdrHcpQ5kTTuNaL4utrmFlMnXCaNzzQ_19YSwasNrFwkic0G8JjogSlaC81_K8Xv8_YrnSt7J6iXOsKl69Wd9VttZxF6_jKlXcQX8YTNyJozhOP5wq40_Zhj2jgrLRVjoSF2mBtD-cD0RcynpfqXjncBwgP15fQIPxFpw6u9xrLTgZbb-8sbiVvuoSPgIBrJwKR3USVizbrIhdEd-Zkzf-lce5SJxDbJ6SkUwLXRGvKAnuAxKU7Bfiu-CCLlmRXcGTN5w5fgdHtfxbhGU43Z-Cdg1NXnB2A4RSZkZmIiwXqjPDohZTrVSNVNR-FtP1W2gf4nR3uPkezgQpnaNoG5p1uWEPqIbr-FGu3g91rorE |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbosYP1CaavRFHGGx9IAY2liEMFmGEN7KPLpKQjmwj_vteKyhPvLW95PqRu16vvf4O4FWNYz0I4mY9YijBWoMy1DkRNN5sJ6HRaBmJTJ3gjtuOr30sWosSrPd_YSRO6LcER0SNilDfC7lfb_4vsSwZW5m_hStsSt_tWcdSdt5xA4_jKlWsXqfvTayJqZhmx58q409Jw57RQHXRVzrRBT6vODzNe-JfyubQqNgXcOohP15cQonxKlTMfe61Kpy5uydvLO60L7-CoSeAlWMRqE78nCXbNenmxDHnZMC_VuFKJM4hXR4TV6aFzomdZgTlgHgZ-4X4TrmoZyxNruHF7s9Mp46jWv4twtKfHk6heQNlnnJ2C4RSpgd6JDwXqrGWQQ2mGrEaqGj9DKZpd1A7xun-OPkZKs7MHS1Hg_HwAc4FSQZK0RqUi2zLHtEkF-GTXMkfG7aNsQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pteridines+Useful+As+HCV+Inhibitors+And+Methods+For+The+Preparation+Thereof&rft.inventor=SIMMEN+KENNETH+ALAN&rft.inventor=RABOISSON+PIERRE+JEAN-MARIE+BERNARD&rft.inventor=LENZ+OLIVER&rft.inventor=LIN+TSE-I&rft.inventor=SURLERAUX+DOMINQUE+LOUIS+NESTOR+GHISLAIN&rft.date=2016-06-09&rft.externalDBID=A1&rft.externalDocID=US2016158238A1 |